These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 16646024

  • 1. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
    Makrygiannakis D, af Klint E, Catrina SB, Botusan IR, Klareskog E, Klareskog L, Ulfgren AK, Catrina AI.
    Arthritis Rheum; 2006 May; 54(5):1463-72. PubMed ID: 16646024
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
    Menezes R, Bramante CM, da Silva Paiva KB, Letra A, Carneiro E, Fernando Zambuzzi W, Granjeiro JM.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
    [Abstract] [Full Text] [Related]

  • 5. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [Abstract] [Full Text] [Related]

  • 6. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [Abstract] [Full Text] [Related]

  • 7. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM, Nishioka K, Yudoh K.
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [Abstract] [Full Text] [Related]

  • 15. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
    [Abstract] [Full Text] [Related]

  • 16. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL, Williams JH, Davie MW, Marshall MJ.
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [Abstract] [Full Text] [Related]

  • 17. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
    Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW.
    Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
    [Abstract] [Full Text] [Related]

  • 18. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.
    af Klint E, Grundtman C, Engström M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK.
    Arthritis Rheum; 2005 Dec; 52(12):3880-9. PubMed ID: 16320336
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Br J Haematol; 2004 Jul; 126(2):244-51. PubMed ID: 15238146
    [Abstract] [Full Text] [Related]

  • 20. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
    Schett G, Middleton S, Bolon B, Stolina M, Brown H, Zhu L, Pretorius J, Zack DJ, Kostenuik P, Feige U.
    Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.